Safety verification trials of mFOLFIRI and sequential IRIS + bevacizumab as first- or second-line therapies for metastatic colorectal cancer in Japanese patients on behalf of tohoku clinical oncology research and education

Shunsuke Kato, Hideaki Andoh, Makio Gamoh, Takuhiro Yamaguchi, Yasuko Murakawa, Hideki Shimodaira, Shin Takahashi, Takahiro Mori, Hisatsugu Ohori, Shun Ichi Maeda, Takao Suzuki, Satoshi Kato, Shoko Akiyama, Yuka Sasaki, Takashi Yoshioka, Chikashi Ishioka

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety verification trials of mFOLFIRI and sequential IRIS + bevacizumab as first- or second-line therapies for metastatic colorectal cancer in Japanese patients on behalf of tohoku clinical oncology research and education'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science